Claudette Loo

基本信息

Career Trajectory

Bio

During the fellowship I focused on the diagnostic imaging of breast cancer, with a special interest in MR imaging and response monitoring of neo-adjuvant chemotherapy. I became a dedicated breast radiologist and settled in the radiology staff and diagnostic research group. Besides the clinical work I finished my PhD entitled 'DCE MRI for monitoring response to neoadjuvant chemotherapy in breast cancer'. I am participating in ongoing research projects concerning mainly neoadjuvant treatment. I am responsible for the fellowship breast radiology.

Research Interests

Papers共 151 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Omitting Axillary Lymph Node Dissection in Breast Cancer Patients with Extensive Nodal Disease and Excellent Response to Primary Systemic Therapy Using the MARI Protocol

Annemiek K.E. van Hemert,Ariane A. van Loevezijn, Marie-Sophie P.D. Baas,Marcel P.M. Stokkel,Emma J. Groen,Vincent van der Noort,Claudette E. Loo,Gabe S. Sonke,Nicola Russell,Frederieke H. van Duijnhoven,Marie-Jeanne T.F.D. Vrancken Peeters

The Breast（2025）

Cited0Views0WOSBibtex

Oncologic Outcome of Response-Guided Axillary Treatment in Patients with Cn1 Breast Cancer after Primary Systemic Therapy

Annemiek van Hemert,Ariane van Loevezijn, Marie-Sophie Baas,Marcel P. Stokkel,Emilie Groen,Vincent van der Noort,Claudette Loo,Gabe S. Sonke,Nicola Russell,Frederieke H. van Duijnhoven,Marie-Jeanne T. F. D. Vrancken Peeters

Journal of Clinical Oncologyno. 16_suppl (2024): 514-514

Cited0Views0Bibtex

LBA11 Neoadjuvant Nivolumab/relatlimab or Nivolumab/ipilimumab in Triple Negative Breast Cancer with High Tumor-Infiltrating Lymphocytes (Tils)

I. Nederlof, A.L. Rolfes, R.C.A.M. Gielen,G. Awada, M.V. Dongen,H.M. Horlings,K. Van De Vijver,C.A. Drukker,F. van Duijnhoven,M. Lopez-Yurda,I. Mandjes,R.M. Mann,C.E. Loo,C.U. Blank,T.N. Schumacher,R.F. Salgado,M. Kok

Annals of Oncology（2024）

Cited0Views0Bibtex

Radiological, Pathological and Surgical Outcomes after Neoadjuvant Endocrine Treatment in Patients with ER-positive/HER2-negative Breast Cancer with a Clinical High Risk and a Low-Risk 70-Gene Signature

Josefien P. van Olmen, Chaja F. Jacobs,Sanne A. L. Bartels,Claudette E. Loo,Joyce Sanders,Caroline A. Drukker,Frederieke H. van Duijnhoven,Marleen Kok

The Breast（2024）

Cited1Views0WOSBibtex

LBA20 First-line Carboplatin-Cyclophosphamide (CC) Versus Paclitaxel (P) with or Without Atezolizumab (atezo) for Metastatic Triple Negative Breast Cancer (mtnbc): Results from a Multicenter, Randomized Phase IIb Trial: the Triple-B Study (BOOG 2013-01)

M. Kok, R.A.B. Voorthuis,L. De Boo,A.G.J. van Rossum,I. Mandjes,S. Balduzzi, M. Chelushkin,E.H. Rosenberg,H.M. Horlings,C.E. Loo,J.B. Heijns, M. Agterhof,B. De Valk, A-M.V. Riel,A. Van Der Velden,M. Dercksen, A. Imholz,A.E. van Leeuwen-Stok,H.M. Oosterkamp,S. Linn

Annals of Oncology（2024）

Cited0Views0Bibtex

The Efficacy of Screening with FDG-PET/CT for Distant Metastases in Breast Cancer Patients Scheduled for Neoadjuvant Systemic Therapy

Jetske L. B. Gunster,Frederieke H. van Duijnhoven,Astrid N. Scholten,Carolien H. Smorenburg,Vincent O. Dezentje,Josefien P. van Olmen,Corrie A. M. Marijnen,Marcel P. M. Stokkel,Claudette E. Loo, A. Marjolein Schrijver

Breast Cancer Research and Treatmentpp.1-8, (2024)

Cited0Views0WOSBibtex

Breast Surgery after Neoadjuvant Chemotherapy in Patients with Lobular Carcinoma: Surgical and Oncologic Outcome

Annemiek van Hemert,Ariane A. van Loevezijn, Anne Bosman, Carmen A. Vlahu,Claudette E. Loo,Marie-Jeanne T. F. D. Vrancken Peeters,Frederieke H. van Duijnhoven,Iris M. C. van der Ploeg

Breast Cancer Research and Treatmentno. 3 (2024): 497-507

Cited1Views0WOSBibtex

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Early-Stage Triple-Negative Breast Cancer: a Phase 2 Adaptive Trial

Iris Nederlof,Olga I. Isaeva, Manon de Graaf, Robbert C. A. M. Gielen,Noor A. M. Bakker, Adrianne L. Rolfes,Hannah Garner,Bram Boeckx,Joleen J. H. Traets,Ingrid A. M. Mandjes,Michiel de Maaker,Thomas van Brussel,Maksim Chelushkin,Elisa Champanhet,Marta Lopez-Yurda,Koen van de Vijver,Jose G. van den Berg,Ingrid Hofland, Natasja Klioueva,Ritse M. Mann,Claudette E. Loo,Frederieke H. van Duijnhoven, Victoria Skinner, Sylvia Luykx,Emile Kerver,Ekaterina Kalashnikova,Marloes G. J. van Dongen,Gabe S. Sonke,Sabine C. Linn,Christian U. Blank,Karin E. de Visser,Roberto Salgado,Lodewyk F. A. Wessels,Caroline A. Drukker,Ton N. Schumacher,Hugo M. Horlings,Diether Lambrechts,Marleen Kok

NATURE MEDICINE (2024)

Cited0Views0WOSNATUREBibtex

Reasons for (non)participation in Supplemental Population-Based MRI Breast Screening for Women with Extremely Dense Breasts

Stefanie G. A. Veenhuizen, Sophie E. L. van Grinsven, Isabelle L. Laseur,Marije F. Bakker,Evelyn M. Monninkhof,Stéphanie V. de Lange,Ruud M. Pijnappel,Ritse M. Mann,Marc B. I. Lobbes,Katya M. Duvivier,Mathijn D. F. de Jong,Claudette E. Loo,Nico Karssemeijer,Paul J. van Diest,Wouter B. Veldhuis,Carla H. van Gils

European radiology（2024）

Cited352Views0WOSBibtex

352

Clinical Implications of Non-Breast Cancer Related Findings on FDG-PET/CT Scan Prior to Neoadjuvant Chemotherapy in Patients with Breast Cancer

Josefien P. van Olmen, A. Marjolein Schrijver,Marcel P. M. Stokkel,Claudette E. Loo, Jetske L. B. Gunster,Marie-Jeanne T. F. D. Vrancken Peeters,Frederieke H. van Duijnhoven,Iris M. C. van der Ploeg

Breast Cancer Research and Treatment（2024）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Radiologist

Papers共 151 篇Author StatisticsCo-AuthorSimilar Experts